RecruitingNCT07292766
Metabolomic Profiling of Patients With Traumatic Brain Injury
Sponsor
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Enrollment
60 participants
Start Date
Feb 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Traumatic Brain Injury (TBI) is a significant cause of mortality and morbidity worldwide. However, the literature on determining its severity and predicting prognosis is insufficient. This study aimed to examine the differences in metabolite levels between trauma patients with severe TBI and orthopedic trauma patients without brain injury.
Eligibility
Min Age: 18 YearsMax Age: 65 Years
Inclusion Criteria3
- Ages 18-65
- Patients diagnosed with severe TBI clinically or according to National Institute for Health and Care Excellence (NICE) criteria (including post-traumatic imaging)
- Patients with non-TBI orthopedic or multitrauma
Exclusion Criteria2
- Presence of brain pathology in the pre-trauma period
- Patient with chronic subdural hematoma
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07292766
Related Trials
A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury
NCT0745513611 locations
Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries
NCT058190081 location
Longitudinal Assessment of Traumatic Microvascular Injury-2
NCT057259931 location
Portable VR-based Chromatic Pupilloperimeter for Diagnosis and Monitoring of Traumatic Brain Injury
NCT074749871 location
Improving Speech in Noise Using Noninvasive Stimulation
NCT071769361 location